Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical fractures, and esophageal cancer, but no stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtado-Navarro, Isabel, García-Sempere, Aníbal, Rodríguez-Bernal, Clara, Sanfélix-Genovés, José, Peiró, Salvador, Sanfélix-Gimeno, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635591/
https://www.ncbi.nlm.nih.gov/pubmed/31354484
http://dx.doi.org/10.3389/fphar.2019.00768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635591/
https://www.ncbi.nlm.nih.gov/pubmed/31354484
http://dx.doi.org/10.3389/fphar.2019.00768

Ejemplares similares